These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

773 related items for PubMed ID: 28098510

  • 1. DT MRI microstructural cortical lesion damage does not explain cognitive impairment in MS.
    Preziosa P, Pagani E, Morelli ME, Copetti M, Martinelli V, Pirro F, Falini A, Comi G, Filippi M, Rocca MA.
    Mult Scler; 2017 Dec; 23(14):1918-1928. PubMed ID: 28098510
    [Abstract] [Full Text] [Related]

  • 2. NODDI, diffusion tensor microstructural abnormalities and atrophy of brain white matter and gray matter contribute to cognitive impairment in multiple sclerosis.
    Preziosa P, Pagani E, Meani A, Marchesi O, Conti L, Falini A, Rocca MA, Filippi M.
    J Neurol; 2023 Feb; 270(2):810-823. PubMed ID: 36201016
    [Abstract] [Full Text] [Related]

  • 3. Impaired cognition is related to microstructural integrity in relapsing remitting multiple sclerosis.
    Zhao L, Ng A, Chen Q, Lam B, Abrigo J, Au C, Mok VCT, Wong A, Lau AY.
    Ann Clin Transl Neurol; 2020 Jul; 7(7):1193-1203. PubMed ID: 32519512
    [Abstract] [Full Text] [Related]

  • 4. Microstructural magnetic resonance imaging of cortical lesions in multiple sclerosis.
    Filippi M, Preziosa P, Pagani E, Copetti M, Mesaros S, Colombo B, Horsfield MA, Falini A, Comi G, Lassmann H, Rocca MA.
    Mult Scler; 2013 Apr; 19(4):418-26. PubMed ID: 22907944
    [Abstract] [Full Text] [Related]

  • 5. The relationship between white matter fiber damage and gray matter perfusion in large-scale functionally defined networks in multiple sclerosis.
    Ma AY, Vitorino RC, Hojjat SP, Mulholland AD, Zhang L, Lee L, Carroll TJ, Cantrell CG, Figley CR, Aviv RI.
    Mult Scler; 2017 Dec; 23(14):1884-1892. PubMed ID: 28178867
    [Abstract] [Full Text] [Related]

  • 6. Contribution of Gray and White Matter Abnormalities to Cognitive Impairment in Multiple Sclerosis.
    Zhang X, Zhang F, Huang D, Wu L, Ma L, Liu H, Zhao Y, Yu S, Shi J.
    Int J Mol Sci; 2016 Dec 27; 18(1):. PubMed ID: 28035997
    [Abstract] [Full Text] [Related]

  • 7. Cortical Perfusion Alteration in Normal-Appearing Gray Matter Is Most Sensitive to Disease Progression in Relapsing-Remitting Multiple Sclerosis.
    Hojjat SP, Kincal M, Vitorino R, Cantrell CG, Feinstein A, Zhang L, Lee L, O'Connor P, Carroll TJ, Aviv RI.
    AJNR Am J Neuroradiol; 2016 Aug 27; 37(8):1454-61. PubMed ID: 27012299
    [Abstract] [Full Text] [Related]

  • 8. Imaging patterns of gray and white matter abnormalities associated with PASAT and SDMT performance in relapsing-remitting multiple sclerosis.
    Riccitelli GC, Pagani E, Rodegher M, Colombo B, Preziosa P, Falini A, Comi G, Filippi M, Rocca MA.
    Mult Scler; 2019 Feb 27; 25(2):204-216. PubMed ID: 29173009
    [Abstract] [Full Text] [Related]

  • 9. Hippocampal and Deep Gray Matter Nuclei Atrophy Is Relevant for Explaining Cognitive Impairment in MS: A Multicenter Study.
    Damjanovic D, Valsasina P, Rocca MA, Stromillo ML, Gallo A, Enzinger C, Hulst HE, Rovira A, Muhlert N, De Stefano N, Bisecco A, Fazekas F, Arévalo MJ, Yousry TA, Filippi M.
    AJNR Am J Neuroradiol; 2017 Jan 27; 38(1):18-24. PubMed ID: 27686487
    [Abstract] [Full Text] [Related]

  • 10. Perfusion reduction in the absence of structural differences in cognitively impaired versus unimpaired RRMS patients.
    Hojjat SP, Cantrell CG, Carroll TJ, Vitorino R, Feinstein A, Zhang L, Symons SP, Morrow SA, Lee L, O'Connor P, Aviv RI.
    Mult Scler; 2016 Nov 27; 22(13):1685-1694. PubMed ID: 26846987
    [Abstract] [Full Text] [Related]

  • 11. Diffusion tensor MRI tractography and cognitive impairment in multiple sclerosis.
    Mesaros S, Rocca MA, Kacar K, Kostic J, Copetti M, Stosic-Opincal T, Preziosa P, Sala S, Riccitelli G, Horsfield MA, Drulovic J, Comi G, Filippi M.
    Neurology; 2012 Mar 27; 78(13):969-75. PubMed ID: 22377806
    [Abstract] [Full Text] [Related]

  • 12. Neuroinflammatory component of gray matter pathology in multiple sclerosis.
    Herranz E, Giannì C, Louapre C, Treaba CA, Govindarajan ST, Ouellette R, Loggia ML, Sloane JA, Madigan N, Izquierdo-Garcia D, Ward N, Mangeat G, Granberg T, Klawiter EC, Catana C, Hooker JM, Taylor N, Ionete C, Kinkel RP, Mainero C.
    Ann Neurol; 2016 Nov 27; 80(5):776-790. PubMed ID: 27686563
    [Abstract] [Full Text] [Related]

  • 13. Detection and quantification of regional cortical gray matter damage in multiple sclerosis utilizing gradient echo MRI.
    Wen J, Yablonskiy DA, Luo J, Lancia S, Hildebolt C, Cross AH.
    Neuroimage Clin; 2015 Nov 27; 9():164-75. PubMed ID: 27330979
    [Abstract] [Full Text] [Related]

  • 14. Changes of brain parenchyma free water fraction reflect tissue damage and impaired processing speed in multiple sclerosis.
    Caporale AS, Chiarelli AM, Biondetti E, Villani A, Lipp I, Di Censo D, Tomassini V, Wise RG.
    Hum Brain Mapp; 2024 Jun 15; 45(9):e26761. PubMed ID: 38895882
    [Abstract] [Full Text] [Related]

  • 15. Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis.
    Papadopoulou A, Müller-Lenke N, Naegelin Y, Kalt G, Bendfeldt K, Kuster P, Stoecklin M, Gass A, Sprenger T, Radue EW, Kappos L, Penner IK.
    Mult Scler; 2013 Sep 15; 19(10):1290-6. PubMed ID: 23459568
    [Abstract] [Full Text] [Related]

  • 16. Comparison of diffusion tensor imaging (DTI) tissue characterization parameters in white matter tracts of patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD).
    Chen X, Roberts N, Zheng Q, Peng Y, Han Y, Luo Q, Feng J, Luo T, Li Y.
    Eur Radiol; 2024 Aug 15; 34(8):5263-5275. PubMed ID: 38175221
    [Abstract] [Full Text] [Related]

  • 17. Brain tissue volumes and relaxation rates in multiple sclerosis: implications for cognitive impairment.
    Megna R, Alfano B, Lanzillo R, Costabile T, Comerci M, Vacca G, Carotenuto A, Moccia M, Servillo G, Prinster A, Brescia Morra V, Quarantelli M.
    J Neurol; 2019 Feb 15; 266(2):361-368. PubMed ID: 30498912
    [Abstract] [Full Text] [Related]

  • 18. Effect of switching from glatiramer acetate 20 mg/daily to glatiramer acetate 40 mg three times a week on gray and white matter pathology in subjects with relapsing multiple sclerosis: A longitudinal DTI study.
    Zivadinov R, Bergsland N, Hagemeier J, Tavazzi E, Ramasamy DP, Durfee J, Cherneva M, Carl E, Carl J, Kolb C, Hojnacki D, Weinstock-Guttman B.
    J Neurol Sci; 2018 Apr 15; 387():152-156. PubMed ID: 29571854
    [Abstract] [Full Text] [Related]

  • 19. Cognitive dysfunction in patients with mildly disabling relapsing-remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging.
    Rovaris M, Iannucci G, Falautano M, Possa F, Martinelli V, Comi G, Filippi M.
    J Neurol Sci; 2002 Mar 30; 195(2):103-9. PubMed ID: 11897239
    [Abstract] [Full Text] [Related]

  • 20. Cognitive impairment and memory disorders in relapsing-remitting multiple sclerosis: the role of white matter, gray matter and hippocampus.
    Sacco R, Bisecco A, Corbo D, Della Corte M, d'Ambrosio A, Docimo R, Gallo A, Esposito F, Esposito S, Cirillo M, Lavorgna L, Tedeschi G, Bonavita S.
    J Neurol; 2015 Jul 30; 262(7):1691-7. PubMed ID: 25957638
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.